oral glutathione randomized controlled trial skin whitening Brightener™ with Ceramosides® Evaluating Oral Glutathione Plus Ascorbic

beta-actin, beta-2-microglobulin, myosin heavy chain 9, ferritin heavy chain, ferritin light chain, major histocompatibility complex class I (HLA-B, HLA-C), S100 calcium binding protein A9 (S100A9), A8 (S100A8), ubiquitin B, C, and ISG15 ubiquitin like modifier (ISG15)) 64

Yet, their method of preparation and the factors studied were quite different from ours

Thus, there is a critical need for improved pathogen- and phenotype-specific diagnosis as well as improved treatment strategies toward better patient outcomes

doi: 10.3389/fmed.2022.795839 [DOI] [PMC free article] [PubMed] [Google Scholar] 45.Pereira JEG, El Dib R, Braz LG, et al

Epistasis-driven identification of SLC25A51 as a regulator of human mitochondrial NAD import